Positions 51–62 of 62.
someone explain thymosin to me like I have not read a paper in years. I am not trying to be the "source?" guy. I would just like a source. The three questions to ask…
24th independent test on CPC — 97.8% on a claimed 97.0%, and the trend is the interesting part. I will put the method line and the batch identifier up front because…
Thinking out loud about this: TB-500 and Thymosin Beta-4 are not the same product and vendors know that. Storage guidance that names a temperature, a state and a…
Proposal, not a decision: the handling rule is doing its job and people should stop complaining. Storage conditions came back specific rather than generic when I asked.…
Vendor-level purity averages over time, built from independent results rather than vendor claims. Transparent methodology, open dataset.
Browse resultsFiling this under things worth writing down: sequence check before price check. every time. Purity methods differ by compound class. A gradient and wavelength developed…
how much of what we believe about secretagogue actually comes from handling threads. Searched first, found three threads that contradict each other, hence the post.…
how do you actually verify handling — that is what I am asking, and I have already read the wiki twice. On the thin testing history in this board, and what to do about…
selectivity claims are usually receptor-panel marketing. One vial, one service, one member paying, which is the only kind of result this board should treat as evidence.…
Something I keep coming back to: handling is doing more work than we give it credit for. Confirmed the lead time in writing before ordering a made-to-order line. It was…
the GH secretagogue story is 30 years old and mostly a cautionary tale, which sounds obvious until you try to state the evidence for it. Figures up front so nobody has…
The title is the argument: we are measuring handling at the wrong time and calling it noise. Here is the rest of it. For any compound with a thin testing history,…
the research peptides advice in here is 3 years out of date. I have gone back and forth on this for months. 3 years — those are the numbers, and they are the ones I am…
The wider research-peptide catalogue: thymosin fragments, GH secretagogues, melanocortin agonists, and the long tail of three-letter analogs. Focus on identity verification, handling and the state of the evidence — not on protocols, because these are not approved for human use.
Independent testing plus vendor-level trend data. Community-funded, unaffiliated.
peptidemeter.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference